| __timestamp | Regeneron Pharmaceuticals, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1271353000 | 31354781 |
| Thursday, January 1, 2015 | 1620577000 | 43445817 |
| Friday, January 1, 2016 | 2052295000 | 66489820 |
| Sunday, January 1, 2017 | 2075142000 | 96886134 |
| Monday, January 1, 2018 | 2186100000 | 153793000 |
| Tuesday, January 1, 2019 | 3036600000 | 148369000 |
| Wednesday, January 1, 2020 | 2735000000 | 151934000 |
| Friday, January 1, 2021 | 2908100000 | 198532000 |
| Saturday, January 1, 2022 | 3592500000 | 112128000 |
| Sunday, January 1, 2023 | 4439000000 | 76192000 |
| Monday, January 1, 2024 | 5132000000 |
Infusing magic into the data realm
In the competitive world of biotechnology, innovation is the lifeblood of success. Regeneron Pharmaceuticals, Inc. and TG Therapeutics, Inc. are two companies that exemplify this drive. Over the past decade, Regeneron has consistently outpaced TG Therapeutics in research and development (R&D) spending, a key indicator of commitment to innovation. From 2014 to 2023, Regeneron's R&D expenses grew by an impressive 250%, peaking at $4.4 billion in 2023. In contrast, TG Therapeutics' R&D investment increased by approximately 140% over the same period, reaching $198 million in 2021 before declining. This disparity highlights Regeneron's robust financial commitment to pioneering new treatments, while TG Therapeutics, though smaller, continues to make significant strides in its niche. As the biotech landscape evolves, these investments will likely shape the future of healthcare innovation.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Blueprint Medicines Corporation
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Pharming Group N.V.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Veracyte, Inc.
Regeneron Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and TG Therapeutics, Inc.
R&D Spending Showdown: TG Therapeutics, Inc. vs CymaBay Therapeutics, Inc.
Analyzing R&D Budgets: TG Therapeutics, Inc. vs Bausch Health Companies Inc.